Hydramine and Quincke's disease - a phase IV clinical study of FDA data
Quincke's disease is found among people who take Hydramine, especially for people who are female, 30-39 old.
The phase IV clinical study analyzes which people take Hydramine and have Quincke's disease. It is created by eHealthMe based on reports of 85,683 people who have side effects when taking Hydramine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
85,683 people reported to have side effects when taking Hydramine.
Among them, 413 people (0.48%) have Quincke's disease.
What is Hydramine?
Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 87,124 Hydramine users for its effectiveness, alternative drugs and more.
What is Quincke's disease?
Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) is found to be associated with 962 drugs and 477 conditions by eHealthMe.
Number of Hydramine and Quincke's disease reports submitted per year:
Gender of people who have Quincke's disease when taking Hydramine*:
Age of people who have Quincke's disease when taking Hydramine *:
Common drugs people take besides Hydramine *:
Common side effects people have besides Quincke's disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Hydramine and have Quincke's disease?Check whether Quincke's disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quincke's disease and when was it recovered:
Expand to all the drugs that have ingredients of diphenhydramine hydrochloride:
Alternative drugs to, pros and cons of Hydramine:
- Hydramine (87,124 reports)
Common Hydramine side effects:
- Fatigue (feeling of tiredness): 8,372 reports
- High blood pressure: 7,844 reports
- Headache (pain in head): 7,424 reports
- Pain: 6,738 reports
- Joint pain: 6,487 reports
- Drug ineffective: 6,238 reports
- Sinusitis (inflammation of sinus): 5,697 reports
- Rashes (redness): 5,569 reports
Browse all side effects of Hydramine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Quincke's disease treatments and more:
- Quincke's disease (16,202 reports)
COVID vaccines that are related to Quincke's disease:
- Quincke's disease in Moderna COVID Vaccine
- Quincke's disease in Pfizer BioNTech Covid Vaccine
- Quincke's disease in Johnson and Johnson Covid Vaccine
Common drugs associated with Quincke's disease:
- Firazyr: 1,985 reports
- Kalbitor: 787 reports
- Heparin: 440 reports
- Hydramine: 413 reports
- Diphen: 413 reports
- Epipen: 379 reports
- Zofran: 293 reports
- Zyrtec: 273 reports
- Benadryl: 260 reports
- Vitamin d: 217 reports
All the drugs that are associated with Quincke's disease:
- Quincke's disease (962 drugs)
Common conditions associated with Quincke's disease:
- Hereditary angioedema: 1,067 reports
- Preventive health care: 680 reports
All the conditions that are associated with Quincke's disease:
- Quincke's disease (477 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on diphenhydramine hydrochloride (the active ingredients of Hydramine) and Hydramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Timolol and Macular Oedema - 16 seconds ago
- Tramadol Hydrochloride and Right Atrial Dilatation - 25 seconds ago
- Invega and Obsessive Thoughts - 37 seconds ago
- Sulfasalazine and Melanoma Recurrent - 44 seconds ago
- Lotrimin and Chest X-Ray Abnormal - 51 seconds ago
- Niaspan and Skin Abscess - 52 seconds ago
- Exondys 51 and Femur Fracture - 54 seconds ago
- Leukine and Gums - Swollen - 55 seconds ago
- Tudorza Pressair and Intraocular Pressure Test Abnormal - a minute ago
- Tradjenta and Idiopathic Pulmonary Fibrosis - a minute ago